Medicare Enrolled

Dr. Neil Dreizen, M.D.

Ophthalmology · Manahawkin, NJ
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
1206 ROUTE 72 W, Manahawkin, NJ 08050
6095978087
In practice since 2006 (20 years)
NPI: 1831149293 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Dreizen from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Dreizen? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Dreizen

Dr. Neil Dreizen is an ophthalmology specialist in Manahawkin, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. Dreizen performed 3,404 Medicare services across 2,920 unique beneficiaries.

Between the years covered by Open Payments, Dr. Dreizen received a total of $2,220 from 27 pharmaceutical and/or device companies across 138 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Dreizen is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 33% volume in NJ $2,220 industry payments

Medicare Practice Summary

Medicare Utilization ↗
3,404
Medicare services
Top 33% in NJ for ophthalmology
2,920
Unique beneficiaries
$66
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~170 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Comprehensive eye exam, established patient
A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider.
1,010 $97 $165
Eye exam, established patient, focused
A limited examination of the visual system for an existing patient. The provider focuses on a specific eye-related concern or symptom.
806 $70 $110
Retinal imaging (OCT scan)
This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye.
456 $32 $95
Visual field test, extended
A test that maps your complete field of vision to detect blind spots or peripheral vision loss. Extended testing provides a more detailed assessment than a standard visual field exam.
383 $50 $125
Optic nerve imaging (OCT scan)
Imaging of the optic nerve.
347 $29 $95
Comprehensive eye exam, new patient
A comprehensive examination of the visual system performed for a new patient.
175 $108 $200
Eye drainage system examination
An examination of the internal drainage system of the eye to assess how fluid flows and drains from the eye.
106 $19 $62
Ultrasound scan of cornea to determine thickness
An ultrasound procedure used to measure the thickness of the cornea.
57 $9 $44
Eyelash removal with forceps
This procedure involves the manual removal of eyelashes using forceps. It is a mechanical extraction method performed on the eyelid area.
28 $17 $152
New patient eye exam, problem focused
A focused examination of the visual system performed during a new patient visit.
21 $65 $115
Laser removal of recurring cataract
A laser procedure to remove a recurring cataract within the lens capsule.
15 $275 $752
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$2,220
Total received (2018-2024)
Avg $317/year across 7 years
Top 36% in NJ for ophthalmology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
27
Companies
138
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,220 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$335
2023
$338
2022
$417
2021
$428
2020
$143
2019
$301
2018
$258

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Oyster Point Pharma, Inc.
$105
Bausch & Lomb Americas Inc.
$67
ABBVIE INC.
$62
Dompe US, Inc.
$51
Alcon Vision LLC
$33
SUN PHARMACEUTICAL INDUSTRIES INC.
$18
Top 3 companies account for 69.6% of 2024 payments
All-time payments by company (2018-2024) ›
Bausch & Lomb Americas Inc.
$211
Bausch & Lomb, a division of Bausch Health US, LLC
$206
Oyster Point Pharma, Inc.
$202
Sun Pharmaceutical Industries Inc.
$181
Mallinckrodt Hospital Products Inc.
$143
Kala Pharmaceuticals, Inc.
$135
Allergan, Inc.
$134
ABBVIE INC.
$118
Novartis Pharmaceuticals Corporation
$117
Alcon Vision LLC
$109
Allergan Inc.
$92
SUN PHARMACEUTICAL INDUSTRIES INC.
$88
Alcon Laboratories Inc
$87
Dompe US, Inc.
$67
Johnson & Johnson Surgical Vision, Inc.
$51
Thea Pharma Inc.
$41
Aerie Pharmaceuticals, Inc.
$39
NEW WORLD MEDICAL,INC.
$37
AbbVie Inc.
$32
Omeros Corporation
$29
RxSight Inc
$23
EyePoint Pharmaceuticals US, Inc.
$15
Ocular Therapeutix, Inc.
$14
Harrow Eye, LLC
$13
Rayner Intraocular Lenses Limited
$13
AbbVie, Inc.
$12
MENICON
$12
Top 3 companies account for 27.9% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ACTIVEFOCUS · ALPHAGAN P · AcrySof · BESIVANCE · BROMSITE · BromSite (bromfenac ophthalmic solution) 0.075% · CEQUA · CEQUA (cyclosporine ophthalmic solution) 0.09% · COMBIGAN · Cequa · Clareon · DEXYCU · DUREZOL · DURYSTA · EYSUVIS · Humira · ILEVRO · INVELTYS · IYUZEH · Kahook Dual Blade · LIGHT ADJUSTABLE LENS (LAL) AND LIGHT DELIVERY DEVICE (LDD) · LOTEMAX · LOTEMAX SM · LUMIGAN · MIEBO · OXERVATE · Omidria · PROLENSA · RESTASIS · RESTASIS MULTIDOSE · ReSure Sealant · Rhopressa · Rocklatan · TOTAL30 · TRAVATAN Z · TYRVAYA · Tecnis IOL · VUITY · VYZULTA · XELPROS · XIIDRA · rocklatan
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an ophthalmology specialist in Manahawkin?
Compare ophthalmologists in the Manahawkin area by procedure volume, costs, and industry payment transparency.
Browse ophthalmologists nearby

Geographic Context

Ophthalmologists within 10 mi
30
Per 100K population
4.6
County median income
$86,411
Nearest hospital
SOUTHERN OCEAN MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Dreizen is a mixed practice specialist, with moderate Medicare volume, with low-engagement industry engagement, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Dreizen experienced with comprehensive eye exam, established patient?
Based on Medicare claims data, Dr. Dreizen performed 1,010 comprehensive eye exam, established patient services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Dreizen receive payments from pharmaceutical companies?
Yes. Dr. Dreizen received a total of $2,220 from 27 companies across 138 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Dreizen's costs compare to other ophthalmologists in Manahawkin?
Dr. Dreizen's average Medicare payment per service is $66. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Dreizen) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →